NON-INVASIVE METHODS TO DETECT PROSTATE CANCER

The present invention is directed to methods of detecting prostate cancer in a sample of a body fluid with prostate cell marker-specific and epithelial cell marker-specific antibodies as well as to kits comprising such antibodies for use in the detection of prostate cancer. The present invention is...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	HOLMES, ERIC, H, MURPHY, GERALD, P, BARREN, ROBERT, J., III, BOYNTON, ALTON, L
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE PHYSICS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS TESTING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention is directed to methods of detecting prostate cancer in a sample of a body fluid with prostate cell marker-specific and epithelial cell marker-specific antibodies as well as to kits comprising such antibodies for use in the detection of prostate cancer. The present invention is also directed to methods of detecting prostate cancer in a sample of a body fluid with prostate cell marker-specific and tumor associated marker-specific antibodies as well as to kits comprising such antibodies for use in the detection of prostate cancer. La présente invention concerne des méthodes permettant de détecter le cancer de la prostate dans un échantillon de liquide organique à l'aide d'anticorps spécifiques de marqueurs des cellules prostatiques et de marqueurs des cellules épithéliales, ainsi que des kits comportant ces anticorps et servant à détecter le cancer de la prostate. La présente invention concerne également des méthodes permettant de détecter le cancer de la prostate dans un échantillon de liquide organique à l'aide d'anticorps spécifiques de marqueurs des cellules prostatiques et de marqueurs liés aux tumeurs, ainsi que des kits comportant ces anticorps et servant à détecter le cancer de la prostate.